Series A - BioSapien
Investment Firm
Overview
BioSapien is a biotech startup focusing on developing a 3D printed drug delivery platform to provide FDA approved drugs.
Announced Date
Nov 01, 2022
Funding Type
Series A
Highlights
Location
New York, New York, United States, North America
Social
Investor Lead
N/A
Participant Investors
3
Round Details and Background
BioSapien raised $35000000 on 2022-11-01 in Series A
BioSapien is a biotech startup focusing on developing a 3D printed drug delivery platform to provide FDA approved drugs.
Company Funding History
8
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 11, 2021 |  Grant - BioSapien | 1 | - | 256.0K |
| Nov 01, 2022 | Series A - BioSapien | 3 | - | 35.0M |
| Jul 19, 2023 | Convertible Note - BioSapien | 1 | - | undefined |
| Feb 21, 2024 | Grant - BioSapien | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.